문의하기 아이콘
문의하기 텍스트
top 아이콘

ECR 2026

Date
March 4–8
Booth Information
Hall X1, No.110
Location
Austria Center Vienna
ECR 2026

ECR 2026 Preview: Moving from Guidelines to Implementation in Lung Cancer Screening

The official theme for ECR 2026 in Vienna is "Rays of Knowledge." Inspired by Athena, the goddess of wisdom, and the Owl—a symbol of vision capable of seeing through darkness—this year’s congress celebrates the radiologist's unique ability to reveal what lies hidden to the ordinary eye.
This theme resonates deeply with Coreline Soft’s mission. Just as the owl sees clearly through the dark, our AI solutions are designed to help radiologists detect the subtlest nodules amidst the noise, sharpening the focus on early diagnosis and patient care.
At ECR 2026, we move beyond theory to practice, demonstrating how these "Rays of Knowledge" are being implemented in national lung cancer screening programs across Europe.

 

Event Overview: ECR 2026

Join Coreline Soft at Europe’s leading radiology congress.
• Date: March 4 ~ 8
• Venue: Austria Center Vienna (ACV), Vienna, Austria
• Booth: Hall X1, No.110
• Official Website: https://www.myesr.org/congress/

 

Why ECR 2026 Matters

Europe has strengthened its lung cancer screening recommendations post-2024. Now, the challenge lies in execution. Building a national screening program requires standardized quality across hundreds of hospitals and diverse imaging equipment.
Therefore, ECR 2026 will move beyond technical showcases to focus on real-world strategies:
• Standardizing Workflows for national programs.
• AI-driven Quality Assurance (QA) to manage high volumes.
• Protocol Consistency across multi-vendor environments.

 

5 Key Trends to Watch

1. Real-World Implementation Leading nations like the Netherlands, Italy, and France are moving fast. Expect deep dives into Centralized Reading models, where AI ensures consistency across decentralized hospital networks.

2. Practical Human-AI Teaming The narrative has shifted from "replacement" to "efficiency." The spotlight will be on Negative Triage—using AI to filter out normal cases so radiologists can focus their expertise on high-risk scans, reducing burnout and improving diagnostic yield.

3. The 'Big-3' Screening Approach One scan, three insights. Analyzing Lung Cancer, COPD, and Coronary Artery Calcium (CAC) simultaneously from a single Low-Dose CT (LDCT) is becoming the new standard for cost-effective preventive care in Europe.

4. Safer Screening with Ultra-Low Dose CT (UL-DCT) To make screening sustainable, radiation safety is paramount. Technologies that enable diagnostic precision even at ultra-low radiation doses (UL-DCT) will be a major topic of discussion.

5. Seamless Integration The best AI is invisible in the workflow. Solutions that integrate flawlessly with PACS and Cloud systems—requiring no extra clicks—will dominate the floor.

 

Coreline Soft at ECR 2026

Coreline Soft isn’t just attending ECR; we are there to set the standard. Our technology is already powering some of Europe’s most significant screening trials:
EU (4-IN-THE-LUNG-RUN): A massive multinational trial spanning 6 countries and 26,000 participants.
Germany (HANSE): The pivotal study validating AI performance in Ultra-Low Dose settings, which laid the groundwork for Germany’s recent mandate for AI usage in national screening.
Italy (RISP): Connecting 18 hospitals via a centralized reading platform.
France (IMPULSION): A strategic implementation study across major French hospital networks.
With AVIEW LCS Plus, we have proven that our AI works in the real world. At ECR 2026, we will showcase the clinical data and operational models that are shaping the future of European lung screening.

ECR 2026 marks the transition to the "Era of AI Standardization." Join Coreline Soft in Vienna to see how validated, field-tested AI solutions are redefining the standard of care in lung cancer screening.

Schedule Your Meeting

Experience Coreline’s solutions.

Please choose a date so that we can help your visit

Contact

Please leave your inquiry if you have any questions regarding our products, recruitment, investment, or any other matters.

Contact us